UVDI-360 Room Sanitizer Inactivates SARS-CoV-2 at 12 Feet Distance in 5 Minutes

UltraViolet Devices Inc. (UVDI) has announced that its UVDI-360 Room Sanitizer achieved greater than 99.99%, or 4log10, inactivation of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in 5 minutes at a distance of 12 feet (3.65 meters).

oneSOURCE Creates Free Resource Page with Up-to-Date COVID-19 Vaccine Information

Today, oneSOURCE, an RLDatix company and leading healthcare management solution, announced a new COVID-19 vaccine resource page to assist healthcare professionals during the initial administration phases of the vaccine.

STERIS to Acquire Cantel Medical

STERIS plc and Cantel Medical Corp. announced that STERIS has signed a definitive agreement to acquire Cantel, through a U.S. subsidiary. Cantel is a global provider of infection prevention products and services primarily to endoscopy and dental Customers.

NEC Releases ‘WISE VISION Endoscopy’ in Europe and Japan

NEC Corporation has announced the development of “WISE VISION Endoscopy,” an AI diagnosis-support medical device software for colonoscopies, which is being released in Japan and is expected to soon be available in Europe.

New PhantomMSK Trauma Application Receives FDA 510(K) Clearance

OrthoGrid Systems, Inc., a global medtech leader in alignment technology for orthopedic surgery, announces today that its newest application, PhantomMSK Trauma, has received 510(K) clearance from the U.S. Food and Drug Administration (FDA).

OrthoGrid Systems’ PhantomMSK is a universal software platform that works with all manufacturer devices across multiple procedures to assist with implant, instrument and anatomic alignment that use fluoroscopic imaging. It is the only intraoperative alignment technology on the market to correct the phenomenon of image distortion in orthopedic surgery, attributed to external electromagnetic interference and the mapping of the planar image on a curved input phosphor, affecting image integrity and causing potential risks of malalignment.

The new Trauma application joins several others on the PhantomMSK platform, including the Hip and Hip Preservation applications, that contribute to improved surgical accuracy and efficiency, leading to better patient outcomes.

The PhantomMSK Trauma application uses software features in conjunction with proprietary algorithms to correct fluoroscopic image distortion. To operate PhantomMSK Trauma, a fluoroscopic image is acquired from a C-arm displayed outside the sterile field, where the image analysis tools can be used at the surgeon’s discretion. OrthoGrid’s intelligence-guided systems are designed to work within the surgical theater flow and interface with existing hospital equipment leading to greater precision and contributing to reduced hospital re-admissions.

“This milestone represents years of scientific research and data, product development and our commitment to empowering surgeons in the OR with advanced decision support tools,” said Edouard Saget, co-founder and CEO of OrthoGrid Systems.

“We will continue to innovate in the market by using emerging technologies in an effort to drive value-based care that benefits patients, hospitals, and surgeons,” added co-founder and CEO of OrthoGrid Systems, Richard Boddington. The PhantomMSK Trauma application will be available in Spring 2020.

For more information, visit



Submit a Comment

Your email address will not be published. Required fields are marked *